Literature DB >> 5852738

The disposition of orally administered cholestyraminec14.

D G Gallo, A L Sheffner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5852738

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  5 in total

1.  Absorption and excretion of colestilan in healthy subjects.

Authors:  Koji Takei; Sian Dale; Heather Charles; Akira Sasaki; Shigekazu Nakajima
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

2.  Effect of cholestyramine on bile acid metabolism in conventional rats.

Authors:  Y Imai; S Kawata; M Inada; S Miyoshi; Y Minami; Y Matsuzawa; K Uchida; S Tarui
Journal:  Lipids       Date:  1987-07       Impact factor: 1.880

3.  Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patient.

Authors:  R B Moore; C A Crane; I D Frantz
Journal:  J Clin Invest       Date:  1968-07       Impact factor: 14.808

4.  Hypercholesteremia. Treatment with cholestyramine, a bile acid sequestering resin.

Authors:  H R Casdorph
Journal:  Calif Med       Date:  1967-04

5.  Sevelamer, a phosphate-binding polymer, is a non-absorbed compound.

Authors:  Melissa A Plone; John S Petersen; David P Rosenbaum; Steven K Burke
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.